These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 307409)

  • 1. Trasylol (aprotinin) as an anti-tumour agent.
    Tweedie DJ; Thomson AW; Horne CH
    Biomedicine; 1978 Feb; 29(1):1-3. PubMed ID: 307409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour activity of aprotinin.
    Latner AL; Longstaff E; Turner GA
    Br J Cancer; 1974 Jul; 30(1):60-7. PubMed ID: 4547138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histological response to a xenogeneic tumour in mice.
    Simpson E; Beverley PC
    Clin Exp Immunol; 1973 Jul; 14(3):443-55. PubMed ID: 4725398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of a synthetic peptide on the cytotoxic activity of the lymphocytes of animals with tumors].
    Landolfo S; Pugliese A
    G Batteriol Virol Immunol; 1975; 68(7-12):240-6. PubMed ID: 1234592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased resistance of C3H/HeHa mice to C3HBA tumor transplants; increased resistance due to supplemental vitamin A.
    Selfter E; Rettura G; Levenson SM
    J Natl Cancer Inst; 1981 Aug; 67(2):467-72. PubMed ID: 6943383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
    Nomi S; Naito K; Kahan BD; Pellis NR
    Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin and growth of Walker 256 carcinosarcoma in the rat.
    Thomson AW; Pugh-Humphreys RG; Horne CH; Tweedle DJ
    Br J Cancer; 1977 Apr; 35(4):454-60. PubMed ID: 300627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms].
    Ramanauskaĭte RIu; Abronina IF; Karaseva LI; Sergeev AV
    Biull Eksp Biol Med; 1994 Sep; 118(9):295-7. PubMed ID: 7819566
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Growth control of experimental tumour. I. Host protection against tumour by previous inoculation of plasmatic membrane of tumour cell (author's transl)].
    Gomes RM; Preza PA; Bastos VC; Coelho MG; Kovary K; de Castro Faria H
    Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):229-35. PubMed ID: 725135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effect of aprotinin upon spleen cells from normal and tumour-bearing mice exposed to PPD and tumour cells.
    Freeman JG; Latner AL; Turner GA; Venables CW
    Experientia; 1980 Feb; 36(2):247-9. PubMed ID: 6154594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression of host versus graft immunity and stimulation of tumor growth following partial hepatectomy.
    Pliskin ME
    Cancer Res; 1976 May; 36(5):1659-63. PubMed ID: 1268827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and cell-mediated immunity. The role of prostaglandin E1 in the induction of host-versus-graft and graft-versus-host reactions in mice.
    Mertin J; Stackpoole A; Shumway SJ
    Transplantation; 1984 Apr; 37(4):396-402. PubMed ID: 6710595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
    Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of "rasayanas", a herbal drug preparation on immune responses and its significance in cancer treatment.
    Kumar VP; Kuttan R; Kuttan G
    Indian J Exp Biol; 1999 Jan; 37(1):27-31. PubMed ID: 10355362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor growth by metyrapone and desoxycorticosterone.
    Rettura G; Sarkar D; Padawer J; Levenson SM; Seifter E
    Surg Forum; 1976; 27(62):153-4. PubMed ID: 1019837
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of aprotinin on immunological resistance in tumour-bearing animals.
    Latner AL; Turner GA
    Br J Cancer; 1976 May; 33(5):535-8. PubMed ID: 1084153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.